News
EDAP
3.370
+1.35%
0.045
Weekly Report: what happened at EDAP last week (0406-0410)?
Weekly Report · 1d ago
EDAP TMS Price Target Cut to $10.00/Share From $14.00 by HC Wainwright & Co.
Dow Jones · 5d ago
EDAP TMS Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 5d ago
HC Wainwright & Co. Maintains Buy on Edap TMS, Lowers Price Target to $10
Benzinga · 5d ago
EDAP TMS price target lowered to $10 from $14 at H.C. Wainwright
TipRanks · 5d ago
Analysts Are Bullish on These Healthcare Stocks: EDAP TMS (EDAP), Ionis Pharmaceuticals (IONS)
TipRanks · 5d ago
EDAP TMS S.A. <EDAP.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $10 FROM $14
Reuters · 5d ago
Weekly Report: what happened at EDAP last week (0330-0403)?
Weekly Report · 04/06 09:29
EDAP TMS Draws EIB Tranche, Issues New Warrants
TipRanks · 04/02 20:58
EDAP TMS issues €3.23 strike warrants for 1.12 million shares to EIB
Reuters · 04/02 20:09
Weekly Report: what happened at EDAP last week (0323-0327)?
Weekly Report · 03/30 09:29
EDAP TMS Earnings Call Highlights HIFU Growth Momentum
TipRanks · 03/28 00:20
EDAP TMS files $125M mixed securities shelf
TipRanks · 03/25 20:30
Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
TipRanks · 03/25 16:01
Edap targets $50M–$54M HIFU revenue for 2026 with continued U.S. and international expansion
Seeking Alpha · 03/25 14:56
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 03/25 12:05
EDAP TMS backs FY26 revenue view $72M-$80M, consensus $75.49M
TipRanks · 03/25 11:45
France's EDAP TMS Q4 revenue beats on HIFU segment strength
Reuters · 03/25 11:40
EDAP TMS reports mixed Q4 results; reaffirms FY26 outlook
Seeking Alpha · 03/25 11:35
Edap TMS Q4 EPS $(0.25) Misses $(0.16) Estimate, Sales $21.880M Beat $21.320M Estimate
Benzinga · 03/25 11:34
More
Webull provides a variety of real-time EDAP stock news. You can receive the latest news about Edap Tms through multiple platforms. This information may help you make smarter investment decisions.
About EDAP
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners